Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Bluebird: on a mission to ‘recode’ the DNA of healthcare

Bluebird: on a mission to ‘recode’ the DNA of healthcare The success or failure of Bluebird will be closely watched by a slew of cell and gene therapy companies including Sangamo, BioMarin (with exciting potential cures for haemophilia) and UniQure, looking

Pfizer buys dwarfism drug company Therachon for $810m

Pfizer buys dwarfism drug company Therachon for $810m Will rival BioMarin pipeline drug. Pfizer is spending $340m to acquire Therachon, a European biotech with a drug in trials for achondroplasia, a form of short-limbed dwarfism. ... Therachon isn’t the only company developing a drug for achondroplasia

EU nod for BioMarin’s second PKU therapy Palynziq

EU nod for BioMarin’s second PKU therapy Palynziq BioMarin has identified Palyniq as having potential to break through the annual $1bn sales mark, but analysts forecast this to be nearer $500m. ... This strategy is in line with BioMarin’s most promising late-stage candidate, valoctocogene

#OrkambiNow?

#OrkambiNow? But Orkambi is not the only orphan disease drug stuck in market access limbo in the England – Biogen’s Spinraza and BioMarin’s Kuvan are both currently suffering similar fates, and

Sangamo surges on data for haemophilia A gene therapy

Sangamo surges on data for haemophilia A gene therapy The new data would seem to put SB-525 firmly in contention with two other haemophilia A gene therapies that have been generating clinical data, namely valoctocogene roxaparvovec (valrox) from BioMarin ... therapies. BioMarin is currently thought to be

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics